Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

NCT06882824 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT06882824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06882824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Recruiting
Start date
March 12, 2025
Completion date
April 17, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myoma;uterus, myomectomy; surgical blood loss